AI Generated Image
Eli Lilly gave mysterious access to weight loss drug to 79-year-old patient
statnews.com • • business
Key Points:
- Eli Lilly's new drug retatrutide has shown weight loss results comparable to bariatric surgery, generating high demand among Americans with obesity.
- Some individuals are attempting to obtain retatrutide through unofficial channels before FDA approval.
- The FDA and Eli Lilly have granted compassionate use access to retatrutide for one patient, a 79-year-old man with a serious, life-threatening condition.
- The case attracted attention from senior health officials, indicating the patient may have significant connections.
